Centerpoint Advisors »

Vyne Therapeutics shares owned by Centerpoint Advisors

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Centerpoint Advisors from 13F filings

Historical chart of Centerpoint Advisors investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Centerpoint Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Centerpoint Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $999 350 2.86
2024-06-30 $999 350 2.86

More positions owned by Centerpoint Advisors

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr S&P SML 600 GWT (IJT)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr Sp Smcp600vl Etf (IJS)

View all positions for Centerpoint Advisors

Top funds holding Vyne Therapeutics

Cormorant Asset Management
Eventide Asset Management
Citadel Advisors
DSC Advisors
Silverarc Capital Management
Palo Alto Investors
Vanguard Group
Exome Asset Management
Parkman Healthcare Partners
AlphaCentric Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Renaissance Technologies
BlackRock
BlackRock

View all funds holding Vyne Therapeutics